New tRNA tech aims to rewrite rare disease treatment
Drug Target Review
JUNE 9, 2025
One company leading the charge in this revolution is Alltrna , whose pioneering work in engineered transfer RNA (tRNA) therapeutics is offering new hope for patients with rare genetic diseases. These codons signal the premature end of protein translation, resulting in truncated or non-functional proteins.
Let's personalize your content